AIKI

Alkido Pharma News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Alkido Pharma Inc AIKI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0385 4.52% 0.89 00:00:02
Open Price Low Price High Price Close Price Prev Close
0.8612 0.8612 0.9077 0.9048 0.8515
more quote information »

Recent News

Date Time Source Heading
5/13/202109:01EDGARCurrent Report Filing (8-k)
5/12/202109:00PRNUSAIkido Pharma Inc. to Present at the Benzinga Global Small..
5/11/202109:20SEEKAIkido Pharma reports Q1 results
5/11/202109:01PRNUSAIkido Pharma Inc. Announces First Quarter 2021 Results and..
5/04/202109:01EDGARStatement of Changes in Beneficial Ownership (4)
5/03/202109:01EDGARCurrent Report Filing (8-k)
4/30/202109:01EDGARStatement of Changes in Beneficial Ownership (4)
4/27/202110:00PRNUSAIkido Pharma Announces Dr. Rachel Yehuda's Appearance at..
4/26/202109:00PRNUSAIkido Pharma Announces Inventor and Scientist Dr. Matthew..
4/23/202111:11EDGARStatement of Changes in Beneficial Ownership (4)
4/22/202109:00PRNUSAIkido Pharma Announces Withdrawal of S-1 Registration..
4/16/202117:16EDGARCurrent Report Filing (8-k)
4/16/202117:16EDGARInitial Statement of Beneficial Ownership (3)
4/16/202110:00PRNUSAIkido Pharma Notes Advancement in Radiopharmaceutical..
4/13/202117:16EDGARCurrent Report Filing (8-k)
4/07/202109:00PRNUSAIkido Granted Sublicense to Technology for Targeted..
4/05/202110:24SEEKAIkido Pharma provides business update
4/05/202109:00PRNUSAIkido Pharma Provides Business Update
3/29/202109:00PRNUSAIkido Pharma Sponsors Psychedelic Compound Research to..
3/25/202118:56EDGARAnnual Report (10-k)
3/12/202110:00PRNUSAIkido Pharma Announces Dr. Matt Frieman's Appearance on..
3/05/202109:01EDGARCurrent Report Filing (8-k)
3/04/202109:00PRNUSAIkido Pharma Inc. Updates Announcement of Webcast Link for..
3/01/202109:00PRNUSAIkido Pharma Inc. to Present at the H.C. Wainwright Global..
2/25/202114:56EDGARStatement of Beneficial Ownership (sc 13d)
2/25/202109:42EDGARStatement of Ownership (sc 13g)
2/23/202110:56PRNUSAIkido Pharma Inc. Announces Exercise of Option to Purchase..
2/22/202111:42SEEKAIkido Pharma provides antiviral platform update
2/22/202109:00PRNUSAIkido Pharma Provides Update on its Antiviral Platform,..
2/19/202111:11PRNUSAIkido Pharma Inc. Announces Closing of $75 Million Bought..
2/18/202117:16EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/17/202108:39SEEKSNDL, IMUX among premarket losers
2/17/202100:27SEEKAIkido Pharma secures $75M via equity raise
2/16/202122:15PRNUSAIkido Pharma Inc. Increases Previously Announced Bought..
2/16/202116:52SEEKAIkido Pharma to raise $10M through bought deal offering
2/16/202116:46PRNUSAIkido Pharma Inc. Announces $10 Million Bought Deal..
2/16/202109:42EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202108:30PRNUSAIkido Pharma Enters Into Letter Of Intent With Silo Pharma..
2/03/202116:32EDGARCurrent Report Filing (8-k)
2/03/202109:00PRNUSAIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to..
2/02/202109:00PRNUSAIkido Pharma Adds Inventor Dr. Neil H. Bander, M.D. to..
2/01/202108:00PRNUSAikido Pharma Secures Early Interest in Next Generation..
1/25/202116:31EDGARCurrent Report Filing (8-k)
1/22/202113:30PRNUSAIkido Pharma Inc. Regains Compliance with NASDAQ Listing..
1/19/202116:30EDGARCurrent Report Filing (8-k)
1/11/202116:33EDGARCurrent Report Filing (8-k)
1/11/202108:30GLOBESilo Pharma Provides Details of Patent License Agreement for..
1/08/202116:51EDGARStatement of Changes in Beneficial Ownership (4)
1/08/202116:42EDGARStatement of Changes in Beneficial Ownership (4)
1/08/202116:41EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
AIKI
Alkido Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.